Suppression of inflammatory and immune responses by the A2A adenosine receptor: an introduction

[1]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[2]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[3]  B. Cronstein,et al.  The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. , 2007, Arthritis and rheumatism.

[4]  A. Ohta,et al.  Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues , 2007, Cancer and Metastasis Reviews.

[5]  Liping Huang,et al.  Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition1 , 2007, The Journal of Immunology.

[6]  S. Einav,et al.  ATTENUATION OF REPERFUSION LUNG INJURY AND APOPTOSIS BY A2A ADENOSINE RECEPTOR ACTIVATION IS ASSOCIATED WITH MODULATION OF Bcl-2 AND Bax EXPRESSION AND ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASES , 2007, Shock.

[7]  S. Colgan,et al.  Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. , 2007, The Journal of clinical investigation.

[8]  G. Beller,et al.  Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  C. Ledent,et al.  Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[10]  Yaqin Xu,et al.  Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes , 2006, Circulation.

[11]  K. Fuxe,et al.  Targeting adenosine A2A receptors in Parkinson's disease , 2006, Trends in Neurosciences.

[12]  Sumio Watanabe,et al.  A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. , 2006, Biochemical and biophysical research communications.

[13]  T. Palmer,et al.  Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells , 2006, Molecular and Cellular Biology.

[14]  S. Friedman,et al.  Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis , 2006, British journal of pharmacology.

[15]  T. Jin,et al.  Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells. , 2006, Endocrinology.

[16]  R. Schrier,et al.  cAMP regulates vasopressin-induced AQP2 expression via protein kinase A-independent pathway. , 2006, Biochimica et biophysica acta.

[17]  K. Taskén,et al.  The molecular machinery for cAMP-dependent immunomodulation in T-cells. , 2006, Biochemical Society transactions.

[18]  K. Taskén,et al.  Compartmentalized cAMP signalling is important in the regulation of Ca(2+) cycling in the heart. , 2006, Biochemical Society transactions.

[19]  C. Müller,et al.  Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. , 2006, Current topics in medicinal chemistry.

[20]  Christopher S. Stevenson,et al.  Effect of adenosine A2A receptor activation in murine models of respiratory disorders. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[21]  E. Deitch,et al.  Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock* , 2006, Critical care medicine.

[22]  Liping Huang,et al.  Renal Ischemia-Reperfusion Injury and Adenosine 2A Receptor-Mediated Tissue Protection: The Role of CD4+ T Cells and IFN-γ1 , 2006, The Journal of Immunology.

[23]  J. Linden,et al.  Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. , 2005, The Biochemical journal.

[24]  J. Zezula,et al.  Heterotrimeric G Protein-independent Signaling of a G Protein-coupled Receptor , 2005, Journal of Biological Chemistry.

[25]  J. Scott,et al.  Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract , 2005, FEBS letters.

[26]  G. Byk,et al.  Involvement of Adenosine in the Antiinflammatory Action of Ketamine , 2005, Anesthesiology.

[27]  A. Ohta,et al.  Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury , 2005, PLoS biology.

[28]  G. Beller,et al.  Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. , 2005, American journal of physiology. Heart and circulatory physiology.

[29]  Liping Huang,et al.  Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. , 2005, American journal of physiology. Renal physiology.

[30]  K. Clark,et al.  The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. , 2005, Biochemical pharmacology.

[31]  S. Colgan,et al.  Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.

[32]  S. Colgan,et al.  Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.

[33]  T. Palmer,et al.  Specific Inhibition of Nuclear Factor-κB–Dependent Inflammatory Responses by Cell Type-Specific Mechanisms upon A2A Adenosine Receptor Gene Transfer , 2004, Molecular Pharmacology.

[34]  B. Cronstein,et al.  Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages , 2004, Journal of leukocyte biology.

[35]  M. Cerqueira.  The future of pharmacologic stress: selective A2A adenosine receptor agonists. , 2004, The American journal of cardiology.

[36]  A. Ohta,et al.  Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo , 2004, The Journal of Immunology.

[37]  Manfred Thiel,et al.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.

[38]  S. Jalkanen,et al.  IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation1 , 2004, The Journal of Immunology.

[39]  Courtney M. Lappas,et al.  Activation of A2A adenosine receptors inhibits expression of α4/β1 integrin (very late antigen‐4) on stimulated human neutrophils , 2004 .

[40]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[41]  B. Cronstein,et al.  Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.

[42]  Liping Huang,et al.  Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. , 2003, The Journal of clinical investigation.

[43]  B. Fredholm,et al.  Signalling from adenosine receptors to mitogen-activated protein kinases. , 2003, Cellular signalling.

[44]  K. Jacobson,et al.  Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.

[45]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[46]  S. Vogel,et al.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.

[47]  M. Sitkovsky.  Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. , 2003, Biochemical pharmacology.

[48]  J. Beavo,et al.  Cyclic nucleotide research — still expanding after half a century , 2002, Nature Reviews Molecular Cell Biology.

[49]  J. Fozard,et al.  Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. , 2002, European journal of pharmacology.

[50]  A. Ohta,et al.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.

[51]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[52]  B. Cronstein,et al.  Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.

[53]  S. Rivkees,et al.  Influences of adenosine on the fetus and newborn. , 2001, Molecular genetics and metabolism.

[54]  C. Hall,et al.  FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. , 2001, European journal of pharmacology.

[55]  T. Skalak,et al.  Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. , 2001, American journal of physiology. Heart and circulatory physiology.

[56]  J. Linden,et al.  Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists , 2001 .

[57]  S. Colgan,et al.  Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function1 , 2000, The Journal of Immunology.

[58]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[59]  E. Ongini,et al.  A2A adenosine receptors in human peripheral blood cells , 2000, British journal of pharmacology.

[60]  M. Freissmuth,et al.  Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21 ras -dependent Pathway* , 1999, The Journal of Biological Chemistry.

[61]  M. Sitkovsky,et al.  Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. , 1999, Molecular pharmacology.

[62]  C. Taylor,et al.  Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.

[63]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[64]  B. Cronstein,et al.  The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. , 1996, Journal of immunology.

[65]  M. Leist,et al.  Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.

[66]  B. Cronstein,et al.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. , 1993, The Journal of clinical investigation.

[67]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[68]  B. Cronstein,et al.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Ghai,et al.  CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. , 1989, The Journal of pharmacology and experimental therapeutics.

[70]  A. Lokshin,et al.  Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-Activated NK cells , 2006, Immunologic research.

[71]  E. Hill,et al.  Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling. , 2006, Current topics in developmental biology.

[72]  B. Cronstein,et al.  Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.

[73]  J. Linden,et al.  Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. , 2001, British journal of pharmacology.

[74]  J. Linden.  Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[75]  M. Leist,et al.  Concanavalin A - induced T-cell - mediated hepatic injury in mice : The role of tumor necrosis factor , 1995 .